0
0
Read Time:12 Second
Dr. Reddy’s Laboratories (DRL) signed a licensing agreement to market in India U.S. biopharmaceutical firm Pharmazz’s Centhaquine, a ‘firstofitskind’ resuscitative agent to treat hypovolemic shock. The product will be distributed by DRL under its…
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %